CommentaryPublished 26 May 2022
Metachronous clear cell bladder metastasis on patients with low risk localized renal cell carcinoma.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Renal Cell Carcinoma (RCC) represents around 5% of grown-up instances of malignant growth in men and 3% in ladies and is the second most normal urologic neoplasm. An expected 18% of patients with RCC have metastasis at analysis (simultaneous metastasis), and over half will create metastatic RCC after nephrectomy during follow-up (metachronous metastasis). The gamble of fostering a metachronous growth is more prominent when there is a family background of RCC, multifocal first renal cell carcinoma, and youthful patient age, or on the other hand assuming the patient has a hereditary malignant growth disorder like Von Hippel-Lindau illness.
Subjects
SurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCase Reports in Surgery and Invasive Procedures
- SubjectSurgery
- BylineArticles whose byline prints “Cheolmin Ji-Min”
